Our data rather suggest that butein effect on breast cancer cells is dependent on its inhibition of AKT phosphorylation, while it was not found in luminal HER2+ breast cancer cell lines such as SKBR-3, HCC-1419 and HCC-2218 cells. This evidence concerns the gene ERBB2 and hepatocellular carcinoma.